Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID

Effect of Home Exercise Activity on Cortisol and Depression in COPD Patients During the Pandemic COVID-19

exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the COVID-19 pandemic.

Study Overview

• Status: Unknown
• Conditions: Chronic Obstructive Pulmonary Disease
• Intervention / Treatment: Behavioral: exercise group; Other: control group

Detailed Description

40 COPD men will be divided to exercise group (20 patients) and control group (20 patients):

the exercise group will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.

The control group will not be trained

• Study Type: Interventional
• Enrollment (Anticipated): 40
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Dokki
    • Giza, Dokki, Egypt
      • Recruiting
      • Faculty of physical therapy cairo university

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

Description

Inclusion Criteria:

• stable COPD patients
• patients who will have a training device as bicycle or treadmill in home

Exclusion Criteria:

• diabetic patients
• renal patients.
• liver diseases

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Exercised group; the exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.	Behavioral: exercise group; the exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.
Other: control group; The control group will not be trained	Other: control group; the control group will not be trained

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
cortisol	it will be measured in plasma	It will be measured after eight weeks of training
hospital anxiety and depression scale	this a questionnaire that will assess anxiety and depression in COPD patients	It will be measured after eight weeks of training

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
pulmonary function test	it will be a measurement for lung volume and capacities	It will be measured after eight weeks of training
Interleukin-8	It is an inflammatory marker in plasma	It will be measured after eight weeks of training
body mass index	it will measure body mass changes	It will be measured after eight weeks of training
six minute walking test	it assess functional capacity	It will be measured after eight weeks of training
St. George's respiratory questionnaire	It assess the effect of COPD on general quality of life	It will be measured after eight weeks of training

Collaborators and Investigators

• Sponsor: Cairo University

Study record dates

Study Major Dates

• Study Start (Actual): November 19, 2020
• Primary Completion (Anticipated): March 1, 2021
• Study Completion (Anticipated): March 1, 2021

Study Registration Dates

• First Submitted: November 19, 2020
• First Submitted That Met QC Criteria: November 19, 2020
• First Posted (Actual): November 20, 2020

Study Record Updates

• Last Update Posted (Actual): November 20, 2020
• Last Update Submitted That Met QC Criteria: November 19, 2020
• Last Verified: November 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
• Other Study ID Numbers: P.T.REC/012/002897

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No